NCT02676076 TRIple in asthMA With uncontRolled pAtient on Medium streNgth of ICS + LABA Status COMPLETED Phase PHASE3
NCT02671643 To Determine the Measurement Properties of the ACT in an African American Adolescent Population With Persistent Asthma Status COMPLETED Phase N/A
NCT02662413 To Determine the Validity of the ACT in an Adolescent Population With Persistent Asthma Status COMPLETED Phase N/A
NCT02660853 Exacerbations in Severe Asthma Patients: Mechanisms and Biomarkers Status COMPLETED Phase NA
NCT02660489 Effect of OC459 on the Response to Rhinovirus Challenge in Asthma Status COMPLETED Phase PHASE2
NCT02655328 Diagnosis et Treatment of Asthma in Athlete : Boundary Between Disease and Doping Status COMPLETED Phase PHASE4
NCT02654145 Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients Status COMPLETED Phase PHASE4
NCT02649803 Pediatric Asthma Control Under Community Management Model in China Status UNKNOWN Phase NA
NCT02649478 Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate Status COMPLETED Phase NA
NCT02648438 A Study to Assess the Bioavailability and to Compare the Pharmacokinetics of AZD7594 Inhaled Via Monodose Inhaler and Multiple-dose Dry Powder Inhalers (DPI) or Pressurized Metered-dose Inhaler (pMDI) in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02645253 A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7594 Inhaled Formulation in Healthy Japanese Men Status COMPLETED Phase PHASE1
NCT02640742 Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting Status COMPLETED Phase N/A